NEW
YORK, Jan. 16, 2025 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of BioAge
Labs, Inc. (NASDAQ: BIOA).
Shareholders who purchased shares of BIOA during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/bioage-labs-inc-loss-submission-form/?id=123060&from=4
CLASS PERIOD: This lawsuit is on behalf of all
shareholders that purchased stock pursuant and/or traceable to
BioAge's registration statement for the initial public offering
held on or about September 26,
2024.
ALLEGATIONS: According to the complaint, on December 6, 2024, BioAge announced that it would
discontinue the ongoing STRIDES Phase 2 trial for azelaprag, its
lead product candidate, citing safety concerns over elevated liver
transaminase levels in participants. This came as a surprise
because, at the time of its IPO less than three months earlier,
BioAge highlighted azelaprag's potential in patients undergoing
obesity therapy with incretin drugs. Following this news,
BioAge's stock price declined from $20.09 per share on December 6, 2024 to $4.65 per share on December 7, 2024.
DEADLINE: March 10, 2025
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/bioage-labs-inc-loss-submission-form/?id=123060&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of BIOA during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is March 10, 2025. There is no cost
or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bioage-labs-inc-sued-for-securities-law-violations---contact-the-gross-law-firm-before-march-10-2025-to-discuss-your-rights--bioa-302352524.html
SOURCE The Gross Law Firm